Loading resource…

BMC
Intensive care unit-acquired infections are a significant cause of morbidity and mortality among critically ill patients. Probiotics have been explored as a preventive strategy, but results from clinical trials have been inconsistent due to variations in strain composition, treatment duration, and dosage. This review systematically analyzes studies to determine the effectiveness of different probiotic regimens in reducing ICU-AIs, focusing on the most beneficial strains and treatment protocols.
No account needed